Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs

Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs

Despite the significant achievements in chemotherapy, cancer remains one of the leading causes of death. Target therapy revolutionized this field, but efficiencies of target drugs show dramatic variation among individual patients. Personalization of target therapies remains, therefore, a challenge i...

Full description

Bibliographic Details
Main Authors: Marianna A. Zolotovskaia, Maxim I. Sorokin, Anna A. Emelianova, Nikolay M. Borisov, Denis V. Kuzmin, Pieter Borger, Andrew V. Garazha, Anton A. Buzdin
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Pharmacology
Subjects:
cancer
DNA mutation
molecular pathways
biomarker
target drugs
tyrosine kinase inhibitors
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00001/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00001/full

Similar Items